Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The cellular basis of protease-activated receptor 2–evoked mechanical and affective pain
Shayne N. Hassler, … , Gregory Dussor, Theodore J. Price
Shayne N. Hassler, … , Gregory Dussor, Theodore J. Price
Published April 30, 2020
Citation Information: JCI Insight. 2020;5(11):e137393. https://doi.org/10.1172/jci.insight.137393.
View: Text | PDF
Research Article Neuroscience

The cellular basis of protease-activated receptor 2–evoked mechanical and affective pain

  • Text
  • PDF
Abstract

Protease-activated receptor 2 (PAR2) has long been implicated in inflammatory and visceral pain, but the cellular basis of PAR2-evoked pain has not been delineated. Although PAR2-evoked pain has been attributed to sensory neuron expression, RNA-sequencing experiments show ambiguous F2rl1 mRNA detection. Moreover, many pharmacological tools for PAR2 are nonspecific, acting also on the Mas-related GPCR family (Mrg) that are highly enriched in sensory neurons. We sought to clarify the cellular basis of PAR2-evoked pain. We developed a PAR2–conditional knockout mouse and specifically deleted PAR2 in all sensory neurons using the PirtCre mouse line. Our behavioral findings show that PAR2 agonist–evoked mechanical hyperalgesia and facial grimacing, but not thermal hyperalgesia, are dependent on PAR2 expression in sensory neurons that project to the hind paw in male and female mice. F2rl1 mRNA is expressed in a discrete population (~4%) of mostly small-diameter sensory neurons that coexpress the Nppb and IL31ra genes. This cell population has been implicated in itch, but our work shows that PAR2 activation in these cells causes clear pain-related behaviors from the skin. Our findings show that a discrete population of DRG sensory neurons mediate PAR2-evoked pain.

Authors

Shayne N. Hassler, Moeno Kume, Juliet M. Mwirigi, Ayesha Ahmad, Stephanie Shiers, Andi Wangzhou, Pradipta R. Ray, Serge N. Belugin, Dhananjay K. Naik, Michael D. Burton, Josef Vagner, Scott Boitano, Armen N. Akopian, Gregory Dussor, Theodore J. Price

×

Figure 3

2AT-evoked Ca2+ signaling is specific for PAR2-expressing neurons.

Options: View larger image (or click on image) Download as PowerPoint
2AT-evoked Ca2+ signaling is specific for PAR2-expressing neurons.
Prima...
Primary mouse DRG cultures were prepared for Ca2+ imaging (A–C) or whole-cell current clamp recordings (D and E). (A) Representative original magnification ×40 images of cultured DRG neurons loaded with Fura 2 at baseline and upon treatment with 2AT (1 μM) and KCl (50 mM), a positive control for neuronal Ca2+ signaling. White arrows highlight an individual cell responsive to both 2AT and KCl (i.e., PAR2+ neurons). Scale bar: 20 μm. (B) Representative traces of 2 cultured DRG neurons showing changes in [Ca2+]i (plotted as 340/380 nm ratiometric change) in response to 2AT and KCl. Baseline measures were recorded for 60 seconds in normal bath solution. Cells were then treated with 2AT (1 μM) for 120 seconds, washed in normal bath solution for 120 seconds, and treated with KCl (50 mM) for 10 seconds. Cells with at least 20% ratiometric change in response to KCl treatment were classified as neurons, and out of these, neurons with at least 40% ratiometric change in response to 2AT treatment were classified as PAR2+. (C) Pie chart illustrating the percentage of PAR2+ neurons in culture as characterized by response to 2AT (1 μM). About 3%–4% of primary cultured DRG neurons (KCl responsive) are PAR2+ (2AT responsive). (D) Whole-cell current clamp recordings reveal increased firing of TRPV1+CGRP– cultured DRG neurons from CGRPcre/+-ER Rosa26LSL-tDTomato/+ TRPV1-GFP reporter mice after activation with 2AT (1 μM). A linear ramp (0 to 0.1 nA for 1 second) was applied to the patched neuron to generate an action potential (AP) train before and after 2AT (1 μM) treatment. (E) Electrophysiological experiments demonstrate that 2AT (1 μM) induced hyperexcitability exclusively in TRPV1+CGRP– neurons. Changes in neuronal excitability were based on the ratio of current ramp-generated AP frequencies after and before vehicle/2AT treatment. n = 7 for TRPV1+CGRP– neurons treated with vehicle, n = 13 for TRPV1+CGRP– neurons treated with 2AT (1 μM), and n = 8 for CGRP+ neurons treated with 2AT (1 μM). Data represent mean ± SEM. One-way ANOVA with Tukey’s multiple comparisons (E) **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts